Biotechnology Assets Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.57	0.2	0.35	0.69	1.68	0.56
Short-Term Investments	0.05	0.07	0.06	0.11	0.04	0.04
Cash & Short-Term Investments	0.62	0.26	0.42	0.8	1.72	0.6
Cash Growth	-8.47%	-37.19%	-47.92%	-53.39%	188.31%	-90.79%
Accounts Receivable	2.41	3.33	3.16	2.21	2.62	2.7
Other Receivables	0.13	0.11	0.19	0.11	0.07	0.05
Receivables	2.54	3.44	3.34	2.32	2.69	2.75
Inventory	-	-	-	-	-	0.02
Total Current Assets	3.15	3.7	3.76	3.12	4.4	3.37
Property, Plant & Equipment	2.26	2.32	2.44	2.53	2.56	2.7
Long-Term Investments	0.45	0.45	0.57	0.37	0.36	0.36
Goodwill	1.14	1.46	2.1	2.74	3.37	4.01
Other Intangible Assets	0.82	0.92	1.14	1.36	1.59	1.83
Long-Term Deferred Tax Assets	2.67	2.67	2.76	3.33	3.33	3.33
Long-Term Deferred Charges	2.96	3.27	3.84	5.03	4.26	4.61
Total Assets	13.46	14.78	16.61	18.47	19.88	20.21
Accounts Payable	0.19	0.2	0.31	0.4	0.3	0.39
Accrued Expenses	0.49	0.87	0.75	0.64	0.8	2.25
Short-Term Debt	0.67	0.75	0.51	0.34	0.33	4.41
Current Portion of Long-Term Debt	0.34	0.46	0.26	0.25	0.21	0.69
Current Portion of Leases	0.02	0.02	0.01	-	-	0.01
Current Income Taxes Payable	0.03	0.04	0.23	0.03	0.06	0.08
Other Current Liabilities	1.34	2.22	1.53	1.88	1.85	1.69
Total Current Liabilities	3.1	4.55	3.61	3.54	3.55	9.52
Long-Term Debt	1.13	0.85	3.32	7.65	7.71	2.41
Long-Term Leases	0.02	0.01	0.03	-	-	-
Long-Term Deferred Tax Liabilities	0.43	0.44	0.51	0.5	0.6	0.67
Other Long-Term Liabilities	2.32	2.32	2.6	2.91	3.67	3.78
Total Liabilities	7.01	8.17	10.08	14.6	15.54	16.37
Common Stock	3.41	3.3	2.89	2.72	2.29	1.97
Additional Paid-In Capital	100.26	99.76	97.12	96.35	95.14	92.15
Retained Earnings	-98.31	-97.52	-94.46	-95.97	-93.89	-90.99
Treasury Stock	-0.02	-0.03	-0.05	-0.03	-0.1	-0.12
Comprehensive Income & Other	1.12	1.09	1.18	0.97	1.04	0.98
Total Common Equity	6.46	6.61	6.68	4.03	4.49	3.99
Minority Interest	-0	-0	-0.15	-0.15	-0.15	-0.15
Shareholders' Equity	6.45	6.61	6.53	3.87	4.34	3.84
Total Liabilities & Equity	13.46	14.78	16.61	18.47	19.88	20.21
Total Debt	2.18	2.09	4.14	8.25	8.25	7.52
Net Cash (Debt)	-1.57	-1.82	-3.72	-7.45	-6.53	-6.92
Net Cash Per Share	-	-0.03	-0.06	-0.14	-0.14	-0.18
Filing Date Shares Outstanding	-	65.97	57.73	54.2	45.61	39.19
Total Common Shares Outstanding	-	65.97	57.73	54.2	45.61	39.19
Working Capital	0.05	-0.85	0.15	-0.41	0.85	-6.15
Book Value Per Share	-	0.10	0.12	0.07	0.10	0.10
Tangible Book Value	4.49	4.23	3.45	-0.07	-0.47	-1.85
Tangible Book Value Per Share	-	0.06	0.06	-0.00	-0.01	-0.05
Land	0.19	0.19	0.19	0.19	0.19	0.19
Buildings	2.57	2.57	2.57	2.57	2.26	2.26
Machinery	1.31	1.31	1.3	1.23	0.42	0.41

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.